Nakagawa, Takahiko
Kang, Duk-Hee
Johnson, Richard J.
Article History
Received: 25 November 2022
Revised: 15 December 2022
Accepted: 20 December 2022
First Online: 16 January 2023
Compliance with ethical standards
:
: RJJ received an honorarium from Horizon Pharma and has equity with Colorado Research Partners LLC. TN and RJJ also have stock with XORTX therapeutics. DH has no disclosures.
Free to read: This content has been made available to all.